Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
出版年份 2020 全文链接
标题
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
作者
关键词
-
出版物
Cellular & Molecular Immunology
Volume 18, Issue 1, Pages 112-127
出版商
Springer Science and Business Media LLC
发表日期
2020-11-24
DOI
10.1038/s41423-020-00572-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
- (2020) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
- (2020) John Alec Moral et al. NATURE
- Neutrophils as emerging therapeutic targets
- (2020) Tamás Németh et al. NATURE REVIEWS DRUG DISCOVERY
- VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance
- (2020) Mohamed A. ElTanbouly et al. SCIENCE
- Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells
- (2020) Silja Steinmann et al. Scientific Reports
- A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC).
- (2020) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of γδT cells in liver diseases and its relationship with intestinal microbiota
- (2020) Qi-Hui Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
- (2020) Stefania Mantovani et al. Cancers
- Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes
- (2020) Di Cao et al. Aging-US
- P-347 A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1
- (2020) B. Sangro et al. ANNALS OF ONCOLOGY
- Cancer immunotherapy with γδ T cells: many paths ahead of us
- (2020) Dieter Kabelitz et al. Cellular & Molecular Immunology
- Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions
- (2020) Malte Deseke et al. Cellular & Molecular Immunology
- Intratumoral γδ T‐cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma
- (2020) Na Zhao et al. HEPATOLOGY
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
- (2020) Hidetaka Yasuoka et al. Scientific Reports
- Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
- (2020) Meir Rozenbaum et al. Frontiers in Immunology
- Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
- (2020) Furong Liu et al. Experimental Hematology & Oncology
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
- (2019) Magnus Rizell et al. Frontiers in Oncology
- Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
- (2019) Biagio Di Lorenzo et al. Cancer Immunology Research
- CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell–Dependent Control of Senescence
- (2019) Jana C. Mossanen et al. GASTROENTEROLOGY
- Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma
- (2019) Meng Duan et al. CLINICAL CANCER RESEARCH
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
- (2019) Shukui Qin et al. Future Oncology
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
- (2019) Thomas Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 3 (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) versus sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy.
- (2019) Robin Kate Kelley et al. JOURNAL OF CLINICAL ONCOLOGY
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hide and seek: Plasticity of innate lymphoid cells in cancer
- (2019) Tobias Bald et al. SEMINARS IN IMMUNOLOGY
- Cancer Immunoediting by Innate Lymphoid Cells
- (2019) Marek Wagner et al. TRENDS IN IMMUNOLOGY
- P-187A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection
- (2019) J Knox et al. ANNALS OF ONCOLOGY
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
- (2019) Qi Zhang et al. GUT
- Chronically stimulated human MAIT cells are unexpectedly potent IL‐13 producers
- (2019) Jason Kelly et al. IMMUNOLOGY AND CELL BIOLOGY
- Tumour-associated neutrophils in patients with cancer
- (2019) Merav E. Shaul et al. Nature Reviews Clinical Oncology
- Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
- (2019) Ashanty M. Melo et al. Frontiers in Immunology
- Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
- (2019) Julián Piñeiro Fernández et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
- (2019) T Yau et al. ANNALS OF ONCOLOGY
- Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
- (2019) Qiming Zhang et al. CELL
- Differential Modulation of Human Innate Lymphoid Cell (ILC) Subsets by IL-10 and TGF-β
- (2019) Sandra Bonne-Année et al. Scientific Reports
- Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes
- (2019) Tsukasa Nabekura et al. IMMUNITY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1
- (2019) Juming Yan et al. Cancer Discovery
- Activated innate lymphoid cell populations accumulate in human tumour tissues
- (2018) Maryam Salimi et al. BMC CANCER
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Therapeutic Immune Modulation Against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
- (2018) Chrisann Kyi et al. CLINICAL CANCER RESEARCH
- Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
- (2018) Yutaka Kurebayashi et al. HEPATOLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
- (2018) Marco Colonna IMMUNITY
- Human blood MAIT cell subsets defined using MR1 tetramers
- (2018) Nicholas A Gherardin et al. IMMUNOLOGY AND CELL BIOLOGY
- Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations
- (2018) Stuart Hunter et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
- (2018) Wing Keung Chan et al. Cancer Immunology Research
- Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
- (2018) Timm Hoeres et al. Frontiers in Immunology
- γδ T cells in liver diseases
- (2018) Xuefu Wang et al. Frontiers of Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
- (2018) Jeong-Hoon Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.
- (2018) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- 209TiPCA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
- (2018) M J Jimenez Exposito et al. ANNALS OF ONCOLOGY
- Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
- (2018) Patrick L. Collins et al. CELL
- High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
- (2018) Adeline Crinier et al. IMMUNITY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
- (2017) Hidetoshi Nakagawa et al. GASTROENTEROLOGY
- Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
- (2017) Ting-ting Wang et al. GUT
- Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
- (2017) Hans J. Hammers et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalized treatment of patients with very early hepatocellular carcinoma
- (2017) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- The role of Kupffer cells in hepatic diseases
- (2017) Peizhi Li et al. MOLECULAR IMMUNOLOGY
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy
- (2017) Dominique Bollino et al. Translational Research
- Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis
- (2017) Jung-Hwan Yu et al. Oncotarget
- Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
- (2017) Nicola Personeni et al. Oncotarget
- Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
- (2017) Xing Li et al. Oncotarget
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
- (2017) S. Meraviglia et al. OncoImmunology
- A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
- (2017) Wenbo Yao et al. EBioMedicine
- Mechanisms Balancing Tolerance and Immunity in the Liver
- (2017) Jan P. Böttcher et al. DIGESTIVE DISEASES
- Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
- (2016) Tobias Eggert et al. CANCER CELL
- Emerging Opportunities and Challenges in Cancer Immunotherapy
- (2016) T. L. Whiteside et al. CLINICAL CANCER RESEARCH
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury
- (2016) Jana C. Mossanen et al. HEPATOLOGY
- A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice
- (2016) Mei Yee Koh et al. HEPATOLOGY
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- Targeting T Cell Co-receptors for Cancer Therapy
- (2016) Margaret K. Callahan et al. IMMUNITY
- Activation strategies for invariant natural killer T cells
- (2016) Ayano C. Kohlgruber et al. IMMUNOGENETICS
- Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
- (2016) Kelly Hudspeth et al. JOURNAL OF AUTOIMMUNITY
- A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis
- (2016) Katrin Neumann et al. JOURNAL OF IMMUNOLOGY
- Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
- (2016) Christoph S N Klose et al. NATURE IMMUNOLOGY
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- Human Vδ2 T cells are a major source of interleukin-9
- (2016) Christian Peters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma
- (2016) Fang-Zhu Ouyang et al. Nature Communications
- Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
- (2016) Guohe Lin et al. Oncotarget
- Novel TGF-β inhibitors ready for prime time in onco-immunology
- (2016) Armand de Gramont et al. OncoImmunology
- CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
- (2016) Kerstin A. Stegmann et al. Scientific Reports
- Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
- (2015) Luciane Zabijak et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Emerging Protumor Role of T Lymphocytes: Implications for Cancer Immunotherapy
- (2015) M. Rei et al. CANCER RESEARCH
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- Myeloid cells in hepatocellular carcinoma
- (2015) Shanshan Wan et al. HEPATOLOGY
- The biliary epithelium presents antigens to and activates natural killer T cells
- (2015) Elisabeth Schrumpf et al. HEPATOLOGY
- Liver inflammation abrogates immunological tolerance induced by Kupffer cells
- (2015) Felix Heymann et al. HEPATOLOGY
- Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
- (2015) You Jeong Lee et al. IMMUNITY
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+monocytes at a site of sterile injury
- (2015) Daniela Dal-Secco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
- (2015) Oscar W.H. Yeung et al. JOURNAL OF HEPATOLOGY
- Cell therapy for liver disease: From liver transplantation to cell factory
- (2015) Stuart J. Forbes et al. JOURNAL OF HEPATOLOGY
- Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ
- (2015) Patrik Sundström et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+NK Cells
- (2015) Nicole Marquardt et al. JOURNAL OF IMMUNOLOGY
- The biology of innate lymphoid cells
- (2015) David Artis et al. NATURE
- Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
- (2015) Shlomi Finkin et al. NATURE IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Immunological landscape and immunotherapy of hepatocellular carcinoma
- (2015) Jesús Prieto et al. Nature Reviews Gastroenterology & Hepatology
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- Low Counts of γδ T Cells in Peritumoral Liver Tissue are Related to More Frequent Recurrence in Patients with Hepatocellular Carcinoma after Curative Resection
- (2014) Xiao-Yan Cai et al. Asian Pacific Journal of Cancer Prevention
- Human innate lymphoid cells
- (2014) M. D. Hazenberg et al. BLOOD
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
- (2014) S. Ma et al. CANCER RESEARCH
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
- (2014) Takeshi Terashima et al. HEPATOLOGY RESEARCH
- γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
- (2014) Pin Wu et al. IMMUNITY
- Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
- (2014) YU SAWADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Macrophage heterogeneity in liver injury and fibrosis
- (2014) Frank Tacke et al. JOURNAL OF HEPATOLOGY
- γδT Cells Drive Myeloid-Derived Suppressor Cell–Mediated CD8+T Cell Exhaustion in Hepatitis B Virus–Induced Immunotolerance
- (2014) Xiaohui Kong et al. JOURNAL OF IMMUNOLOGY
- γ/δ T cell subsets in human aging using the classical α/β T cell model
- (2014) Anusha Vasudev et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Hepatitis B virus infection
- (2014) Christian Trépo et al. LANCET
- MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
- (2014) A Kurioka et al. Mucosal Immunology
- Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
- (2014) Elisa Gomez Perdiguero et al. NATURE
- T-cell activation by transitory neo-antigens derived from distinct microbial pathways
- (2014) Alexandra J. Corbett et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
- (2014) Meixiao Shen et al. PLoS One
- Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease
- (2014) Neil Rajoriya et al. Frontiers in Immunology
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
- (2013) Xiaozhou Yu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
- (2013) Rangsima Reantragoon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
- (2013) A. Wehr et al. JOURNAL OF IMMUNOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells
- (2013) Kelly Hudspeth et al. Frontiers in Immunology
- Tumor cell recognition by γδ T lymphocytes
- (2013) Daniel V. Correia et al. OncoImmunology
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
- (2012) Q. Gao et al. CANCER RESEARCH
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
- (2012) Wing-Kin Syn et al. GUT
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Natural killer cells in liver disease
- (2012) Zhigang Tian et al. HEPATOLOGY
- Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
- (2012) FUJIMASA TADA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
- (2012) Mervat El Ansary et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner
- (2012) Yong Yi et al. JOURNAL OF HEPATOLOGY
- NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
- (2012) Andreas Glässner et al. LABORATORY INVESTIGATION
- MR1 presents microbial vitamin B metabolites to MAIT cells
- (2012) Lars Kjer-Nielsen et al. NATURE
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Differentiation, phenotype, and function of interleukin-17-producing human V 9V 2 T cells
- (2011) N. Caccamo et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
- (2011) Tuanjie Li et al. CANCER LETTERS
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
- (2011) Bin Gao et al. GASTROENTEROLOGY
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
- (2011) Valerie Chew et al. GUT
- Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function
- (2011) James A. Thomas et al. HEPATOLOGY
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- (2011) Pierre-Alain Clavien et al. LANCET ONCOLOGY
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
- (2011) Tae-Won Kang et al. NATURE
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
- (2010) M. Dusseaux et al. BLOOD
- Elevation of activated γδ T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease
- (2010) L. WEN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Promoting angiogenesis within the tumor microenvironment: The secret life of murine lymphoid IL-17-producing γδ T cells
- (2010) Bruno Silva-Santos EUROPEAN JOURNAL OF IMMUNOLOGY
- Tolerogenic plasmacytoid DC
- (2010) Benjamin M. Matta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease
- (2010) Wing-Kin Syn et al. HEPATOLOGY
- Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
- (2010) Yi-Wei Li et al. JOURNAL OF HEPATOLOGY
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- Cytokine Requirements for the Differentiation and Expansion of IL-17A- and IL-22-Producing Human V 2V 2 T Cells
- (2010) K. J. Ness-Schwickerath et al. JOURNAL OF IMMUNOLOGY
- Antimicrobial activity of mucosal-associated invariant T cells
- (2010) Lionel Le Bourhis et al. NATURE IMMUNOLOGY
- iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
- (2010) Matteo Bellone et al. PLoS One
- Type I natural killer T cells suppress tumors caused by p53 loss in mice
- (2009) J. B. Swann et al. BLOOD
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Toll-like receptors as targets in chronic liver diseases
- (2009) A Mencin et al. GUT
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- Enrichment of Human CD4+ V 24/V 11 Invariant NKT Cells in Intrahepatic Malignant Tumors
- (2009) G. Bricard et al. JOURNAL OF IMMUNOLOGY
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
- (2008) D. Y. Chiang et al. CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
- (2008) Daniel H. Palmer et al. HEPATOLOGY
- High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
- (2008) Tong Ding et al. HUMAN PATHOLOGY
- TLR-dependent cross talk between human Kupffer cells and NK cells
- (2008) Zhengkun Tu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natural killer cell recognition of missing self
- (2008) Klas Kärre NATURE IMMUNOLOGY
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started